Omentin-1 vs GHRP-6
Head-to-head comparison of Omentin-1 (Omentin-1 (Intelectin-1, ITLN1)) and GHRP-6 (Growth Hormone Releasing Peptide-6) — benefits, dosing, side effects, research data, and where to buy.
| Property | Omentin-1 | GHRP-6 |
|---|---|---|
| Category | Diabetes & Metabolic | Performance |
| Full Name | Omentin-1 (Intelectin-1, ITLN1) | Growth Hormone Releasing Peptide-6 |
| Molecular Weight | ~35 kDa | 873.01 Da |
| Half-Life | hours | ~15-60 minutes |
| Amino Acids | 313 | 6 |
| Typical Dose | No approved human dose; research use only | 100-300 mcg |
| Route | IV|SC | SC / IV |
| Purity | ≥98% | — |
| Studies Count | 82 | 186 |
| Research Status | Pre-clinical | Clinical Trials |
Omentin-1 Benefits
- ✓insulin sensitivity
- ✓glucose uptake
- ✓lipid handling
GHRP-6 Benefits
- ✓Potent GH release stimulation
- ✓Muscle growth and strength
- ✓Appetite stimulation (ghrelin pathway)
- ✓Improved body composition
- ✓Enhanced recovery from training
Omentin-1 Dosing
not established|not established
GHRP-6 Dosing
Standard: 100-300 mcg SC 2-3 times daily|Pre-workout: 100 mcg 30 min before training|Pre-bed: 100-200 mcg for overnight GH pulse
Omentin-1 Side Effects
- ⚠unknown
- ⚠immunogenicity risk
GHRP-6 Side Effects
- ⚠Common: Increased appetite (significant), water retention, tingling
- ⚠Moderate: Cortisol elevation (dose-dependent), lethargy
- ⚠Rare: Elevated prolactin at high doses
Research Overview
Omentin-1
Lower omentin-1 levels are often associated with obesity, insulin resistance, and metabolic syndrome. Research continues on its use as a biomarker and as a mechanistic lead for AMPK-linked metabolic interventions.
GHRP-6
GHRP-6 has solid pre-clinical and clinical evidence for GH stimulation. Well-characterized pharmacology. More appetite stimulation than Ipamorelin due to ghrelin receptor activation.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.